SASKATOON – A University of Saskatchewan (USask) medical research team has made a ground-breaking finding with potential to lead to more effective, longer-lasting and better-tolerated treatments for cystic fibrosis (CF).
“Though we’re still at an early stage for developing new treatments, this is a major discovery of considerable potential relevance to CF patients,” said Dr. Juan Ianowski (PhD), a physiologist at the USask College of Medicine and senior author of a paper on the finding published today in the online Nature Research journal Scientific Reports.
